ADA 2022: Once-Weekly Dulaglutide Tied to Improved Glycemic Control in Young People
Treatment was safe, effective through 26 weeks among youth ages 10 to 18 years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.